0001437749-18-004969.txt : 20180319 0001437749-18-004969.hdr.sgml : 20180319 20180319171214 ACCESSION NUMBER: 0001437749-18-004969 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180315 FILED AS OF DATE: 20180319 DATE AS OF CHANGE: 20180319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Keiley Elizabeth M CENTRAL INDEX KEY: 0001629085 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36200 FILM NUMBER: 18699668 MAIL ADDRESS: STREET 1: C/O OXFORD IMMUNOTEC GLOBAL STREET 2: 94C INNOVATION DRIVE, MILTON PARK CITY: ABINGDON, OXFORDSHIRE STATE: X0 ZIP: OX14 4RZ ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oxford Immunotec Global PLC CENTRAL INDEX KEY: 0001586049 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 94C INNOVATION DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ BUSINESS PHONE: 44 01235 442780 MAIL ADDRESS: STREET 1: 94C INNOVATION DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ 4 1 rdgdoc.xml FORM 4 X0306 4 2018-03-15 0001586049 Oxford Immunotec Global PLC OXFD 0001629085 Keiley Elizabeth M C/O OXFORD IMMUNOTEC GLOBAL PLC 94C INNOVATION DRIVE ABINGDON, OXFORDSHIRE X0 OX14 4RZ UNITED KINGDOM 1 Senior VP & General Counsel Ordinary Shares 2018-03-15 4 A 0 10882 0 A 35133 D Share Option (Right to Buy) 13.24 2018-03-15 4 A 0 47587 0 A 2028-03-15 Ordinary Shares 47587 47587 D Options granted under Issuer's 2013 Share Incentive Plan. Options will become exercisable ratably on the anniversary of the vesting start date from January 1, 2019 through January 1, 2022. /s/ Elizabeth M. Keiley 2018-03-19